52 research outputs found

    Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: A Systematic Review

    Get PDF

    Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial.

    Get PDF
    OBJECTIVES: The aim of the study was to evaluate the effects of infant formula supplemented with 2 human milk oligosaccharides (HMOs) on infant growth, tolerance, and morbidity. METHODS: Healthy infants, 0 to 14 days old, were randomized to an intact-protein, cow's milk-based infant formula (control, n\u200a=\u200a87) or the same formula with 1.0\u200ag/L 2'fucosyllactose (2'FL) and 0.5\u200ag/L lacto-N-neotetraose (LNnT) (test, n\u200a=\u200a88) from enrollment to 6 months; all infants received standard follow-up formula without HMOs from 6 to 12 months. Primary endpoint was weight gain through 4 months. Secondary endpoints included additional anthropometric measures, gastrointestinal tolerance, behavioral patterns, and morbidity through age 12 months. RESULTS: Weight gain was similar in both groups (mean difference [95% confidence interval] test vs control: -0.30 [-1.94, 1.34] g/day; lower bound of 95% confidence interval was above noninferiority margin [-3\u200ag/day]). Digestive symptoms and behavioral patterns were similar between groups; exceptions included softer stool (P\u200a=\u200a0.021) and fewer nighttime wake-ups (P\u200a=\u200a0.036) in the test group at 2 months. Infants receiving test (vs control) had significantly fewer parental reports (P\u200a=\u200a0.004-0.047) of bronchitis through 4 (2.3% vs 12.6%), 6 (6.8% vs 21.8%), and 12 months (10.2% vs 27.6%); lower respiratory tract infection (adverse event cluster) through 12 months (19.3% vs 34.5%); antipyretics use through 4 months (15.9% vs 29.9%); and antibiotics use through 6 (34.1% vs 49.4%) and 12 months (42.0% vs 60.9%). CONCLUSIONS: Infant formula with 2'FL and LNnT is safe, well-tolerated, and supports age-appropriate growth. Secondary outcome findings showing associations between consuming HMO-supplemented formula and lower parent-reported morbidity (particularly bronchitis) and medication use (antipyretics and antibiotics) warrant confirmation in future studies

    Infant formulae: how well are they tested?

    No full text

    Work profile of Belgian paediatricians in regional and university hospitals

    No full text

    Hospital-related undernutrition in children: still an often unrecognized and undertreated problem.

    No full text
    To evaluate the nutritional status of hospitalized children in Belgian hospitals and to analyse the impact of undernutrition on the degree of weight loss and duration of hospitalization.Journal ArticleSCOPUS: ar.jFLWINinfo:eu-repo/semantics/publishe
    corecore